BEACOPP Protocol in 60 Children with Hodgkin's Lymphoma (HL): Multicenter Experience in Venezuela
G Correles de Acquatella, R Garcia Guevara, R Montilva, B Urdaneta de Ramos, N Rojas, A Paez, D Falcon, O Carrasquel, M Rivero, S Pachano, L Cardenas, M Mejias, C Sarache, E Montero, MA Torres, M Marval, C Mendoza, N Barrios · Klinische Pädiatrie · 2014 · Heft 03
Bibliografische Angaben
Zusammenfassung
Introduction: Between 2006 – 2009, 52 children receiving BEACOP scheme (due to unavailable Procarbazine in Venezuela) had unsatisfactory results. Since Procarbazine was available, 60 patients (pts) treated with BEACOPP from 2008 to 2013 are now presented. Patients and methods: From July 2008 to May 2013, 60 pts < 19 years, newly diagnosed HL were included. There were 36 males (60%), mean age 12.8 ± 4 SD yrs. Prognostics factors (PF) were: clinical stage, B symptoms, bulky disease ≥5 cm, ≥4 nodal regions, mediastinal mass ≥30% t.d, sedimentation rate ≥50 mm 1st h. We had 2 groups: Favorable Group (FG): ≤2 PF, Unf…
